DWTX
Dogwood Therapeutics, Inc.
NASDAQ: DWTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
+5.93% today
Updated 2026-04-30
Market cap
$46.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$1 – $10
Volume
0.1M
Dogwood Therapeutics, Inc. (DWTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.20M | $-2.09M | $-3.90M | $-15.69M | $-11.47M | $-4.87M | $-8.79M | $-15.62M |
| Capital expenditures | $0.00 | $0.00 | $5.00 | $0.00 | $3.00 | $0.00 | $5.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $7.43M | $322881.00 | $582659.00 | $619972.00 | $476021.00 | $355642.00 |
| Free cash flow | $-1.20M | $-2.09M | $-3.90M | $-15.69M | $-11.47M | $-4.87M | $-8.79M | $-15.62M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $75000.00 | $0.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |